4583 — Chiome Bioscience Balance Sheet
0.000.00%
Annual balance sheet for Chiome Bioscience, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,791 | 1,727 | 1,326 | 2,063 | 1,205 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 61.5 | 145 | 108 | 75.5 | 102 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,217 | 2,092 | 1,629 | 2,338 | 1,547 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.2 | 2.44 | 1.17 | 0 | 36.3 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,339 | 2,215 | 1,751 | 2,469 | 1,728 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 393 | 370 | 539 | 493 | 375 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 446 | 425 | 594 | 549 | 605 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,893 | 1,791 | 1,158 | 1,920 | 1,122 |
| Total Liabilities & Shareholders' Equity | 2,339 | 2,215 | 1,751 | 2,469 | 1,728 |
| Total Common Shares Outstanding |